athenahealth, Inc. (NASDAQ:ATHN) released its quarterly earnings results on Thursday. The health services provider reported $0.51 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.39 by $0.12, Bloomberg Earnings reports. The business had revenue of $301.10 million during the quarter, compared to analyst estimates of $298.68 million. athenahealth had a net margin of 1.84% and a return on equity of 5.93%. The business’s revenue was up 15.0% on a year-over-year basis. During the same period last year, the business earned $0.34 EPS.

athenahealth (NASDAQ:ATHN) traded up 0.29% on Thursday, hitting $143.80. 2,805,349 shares of the stock traded hands. The firm has a market cap of $5.73 billion, a price-to-earnings ratio of 283.07 and a beta of 1.79. athenahealth has a 12-month low of $90.11 and a 12-month high of $149.55. The stock has a 50-day moving average of $141.23 and a 200-day moving average of $122.47.

In other news, CEO Jonathan Bush sold 8,000 shares of the company’s stock in a transaction dated Tuesday, April 25th. The shares were sold at an average price of $120.00, for a total value of $960,000.00. Following the sale, the chief executive officer now owns 319,807 shares of the company’s stock, valued at approximately $38,376,840. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP Bradford Kyle Armbrester sold 2,431 shares of the company’s stock in a transaction dated Thursday, May 18th. The stock was sold at an average price of $130.00, for a total transaction of $316,030.00. The disclosure for this sale can be found here. Insiders sold a total of 25,683 shares of company stock worth $3,329,871 in the last three months. Insiders own 3.20% of the company’s stock.

A number of equities research analysts recently weighed in on the stock. Oppenheimer Holdings, Inc. reaffirmed an “outperform” rating and set a $142.00 price target on shares of athenahealth in a report on Wednesday, April 19th. UBS AG set a $123.00 price target on shares of athenahealth and gave the company a “buy” rating in a report on Monday, May 1st. Piper Jaffray Companies reaffirmed a “buy” rating and set a $152.00 price target on shares of athenahealth in a report on Friday, July 14th. Barclays PLC set a $88.00 price target on shares of athenahealth and gave the company an “underweight” rating in a report on Monday, May 1st. Finally, Leerink Swann set a $140.00 price target on shares of athenahealth and gave the company a “hold” rating in a report on Friday, May 19th. One investment analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and twelve have assigned a buy rating to the company. athenahealth has an average rating of “Hold” and a consensus price target of $141.00.

TRADEMARK VIOLATION WARNING: “athenahealth, Inc. (ATHN) Issues Earnings Results, Beats Expectations By $0.12 EPS” was originally posted by American Banking News and is owned by of American Banking News. If you are reading this report on another site, it was illegally copied and reposted in violation of United States & international copyright laws. The original version of this report can be viewed at https://www.americanbankingnews.com/2017/07/20/athenahealth-inc-athn-issues-earnings-results-beats-expectations-by-0-12-eps.html.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Earnings History for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.